Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bide Pharmatech CoSHSE:688073 +9.28%86 Days Inventory is 532.49 as of Mar. 2026, which is 32% above its 10-year median of 402.45. GuruFocus rates SHSE:688073 with a GF Score™ of 86/100 and a GF Value™ of ¥67.40 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Bide Pharmatech Co ranks worse than 94.04% on this metric.
The historical rank and industry rank for Bide Pharmatech Co's Days Inventory or its related term are showing as below:
SHSE:688073'
s Days Inventory Range Over the Past 10 Years
Min: 340.22 Med: 402.45 Max: 447.91
Current: 447.91
During the past 8 years, Bide Pharmatech Co's highest Days Inventory was 447.91. The lowest was 340.22. And the median was 402.45.
SHSE:688073's Days Inventory is ranked worse than 94.04% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs SHSE:688073: 447.91
Bide Pharmatech Co's Days Inventory
increased
from Mar. 2025 (432.02) to Mar. 2026 (532.49).
It might indicate that Bide Pharmatech Co's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bide Pharmatech Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.17.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bide Pharmatech Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 2.98.
Bide Pharmatech Co (SHSE:688073) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bide Pharmatech Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bide Pharmatech Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Bide Pharmatech Co Days Inventory Related Terms
Bide Pharmatech Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Bide Pharmatech Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bide Pharmatech Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bide Pharmatech Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bide Pharmatech Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bide Pharmatech Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bide Pharmatech Co (SHSE:688073) has a Days Inventory of 532.49 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bide Pharmatech Co and its competitors. This is 32% above median its historical median of 402.45. Over the past decade, Bide Pharmatech Co's Days Inventory has ranged from 340.22 to 447.91. According to the industry distribution chart, Bide Pharmatech Co ranks #868 out of 923 companies in the Drug Manufacturers industry, placing it in the top 94%.
Is Bide Pharmatech Co's Days Inventory too high?
Bide Pharmatech Co's current Days Inventory of 532.49 is 32% above median its 10-year median of 402.45. Over the past 10 years, this metric has ranged from a low of 340.22 to a high of 447.91. The Drug Manufacturers industry median Days Inventory is 164.87. Bide Pharmatech Co's value of 532.49 is 223% above this industry median. Based on the distribution chart, Bide Pharmatech Co ranks #868 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Bide Pharmatech Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bide Pharmatech Co's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Bide Pharmatech Co ranks #868 out of 923 companies for Days Inventory. This places Bide Pharmatech Co in the lower half of its industry. The industry median Days Inventory is 164.87. Bide Pharmatech Co's value of 532.49 is 223% above this benchmark. Historically, Bide Pharmatech Co's own Days Inventory has ranged from 340.22 to 447.91 over the past decade. While the company's 10-year median is 402.45 vs. the industry median of 164.87, Bide Pharmatech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bide Pharmatech Co's current Days Inventory of 532.49 is 223% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bide Pharmatech Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bide Pharmatech Co's current Days Inventory is 532.49, which is 32% above median its own 10-year median of 402.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bide Pharmatech Co stock overvalued right now?
Based on GuruFocus' analysis, Bide Pharmatech Co (SHSE:688073) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥67.40, compared to a current price of ¥50.65 — trading 24.9% below its estimated fair value. The current Days Inventory is 532.49, which is 32% above median its 10-year median of 402.45 and 223% above the Drug Manufacturers industry median of 164.87. Bide Pharmatech Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bide Pharmatech Co (SHSE:688073), the current Days Inventory is 532.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bide Pharmatech Co (SHSE:688073) Overvalued in 2026?
Based on GuruFocus' analysis, Bide Pharmatech Co stock appears to be undervalued.
The current stock price of ¥50.65 is trading 24.9% below its estimated GF Value™ of ¥67.40.
GuruFocus considers Bide Pharmatech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688073:
Days Inventory: 532.49 (32% above median its 10-year median of 402.45)
GF Value™: ¥67.40 vs. price of ¥50.65 (24.9% below fair value)
Industry Position: 223% above the Drug Manufacturers median (#868 of 923)
No single metric tells the full story. See the SHSE:688073 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688073 has been successfully added to your 
